Dual-action therapy targeting both GIP and GLP-1 receptors for superior appetite suppression and enhanced metabolic results
During summer months, when social events, barbecues, and vacations are frequent, they shift their injection day so peak effects cover weekends
Once injected, the medication stays in your system for several days, with a half-life of about 7 days
Diabetes, Obesity and Metabolism, 16(1), pp.921
At the systemic level, GLP-1 RAs improve insulin sensitivity in peripheral tissues (muscle, adipose), reduce circulating free fatty acid flux to the liver, suppress hypothalamic appetite circuits to promote weight loss, and lower systemic pro-inflammatory cytokines (TNF-, IL-1, IL-6), thereby reducing the hepatic inflammatory milieu indirectly [7,26,30]